To allow US-based researchers to join with their European counterparts in the rigorous process of determining the fraction of negative health endpoints that can be attributed to exposure to endocrine disrupting chemicals.
To allow US-based researchers to join with their European counterparts in the rigorous process of determining the fraction of negative health endpoints that can be attributed to exposure to endocrine disrupting chemicals.